{"id":409760,"date":"2021-01-06T13:24:49","date_gmt":"2021-01-06T18:24:49","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409760"},"modified":"2021-01-06T13:24:49","modified_gmt":"2021-01-06T18:24:49","slug":"important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/","title":{"rendered":"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Jan.  06, 2021  (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fortress Biotech, Inc. (NASDAQ: FBIO) from December 11, 2019 through October 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Fortress Biotech, Inc. investors under the federal securities laws.<\/p>\n<p>To join the class action, go <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P4kp4nJdY4n_bF2o4xoAqm16cyadDQuwmKkpmPHsbWOj7DKUsGZ1Ts-QT72WNwVmmZWzIvkrXtMtfIRY6MG7552Bu7nrFenN2ZeEkgm6aSefLYe5MRdZkgFkbFIhJtVM4OkVh1_G-NtUHJxhSJV0dQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a> or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KESfxcN9QJxp8IyiwgNfZg5txlN5oa7QrMzEeo6AeVijGj4U71UoSX5gJROYdLdOb9Prsav-0Hk5TzcciNYesGRDg2aFNc7SKDuV6erRvgM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@pawarlawgroup.com<\/a>\u00a0for information on the class action.<\/p>\n<p>According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: (1) IV Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the FDA would not approve the NDA for IV Tramadol; and (3) as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.<\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court no later than <strong>January 26, 2021<\/strong>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.<\/p>\n<p>No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.<\/p>\n<p>Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.<br \/>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>Contact:\u00a0\u00a0<br \/>Vik Pawar, Esq.\u00a0\u00a0<br \/>Pawar Law Group\u00a0\u00a0<br \/>20 Vesey Street, Suite 1410\u00a0\u00a0<br \/>New York, NY 10007\u00a0\u00a0<br \/>Tel: (917) 261-2277\u00a0\u00a0<br \/>Fax: (212) 571-0938\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KESfxcN9QJxp8IyiwgNfZg5txlN5oa7QrMzEeo6AeVg4VICY3DU5eRfW0nSMAi4vC7h-LmlNv1gmYJ0Z6GkxH3UAt7oNnAY8rSsMCDLm4Ho=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@pawarlawgroup.com<\/a>\u00a0<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/cfacab7f-a746-4444-8e44-0038bf59a424\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fortress Biotech, Inc. (NASDAQ: FBIO) from December 11, 2019 through October 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Fortress Biotech, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0info@pawarlawgroup.com\u00a0for information on the class action. According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: (1) IV Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the FDA would &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409760","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fortress Biotech, Inc. (NASDAQ: FBIO) from December 11, 2019 through October 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Fortress Biotech, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0info@pawarlawgroup.com\u00a0for information on the class action. According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: (1) IV Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the FDA would &hellip; Continue reading &quot;IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T18:24:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO\",\"datePublished\":\"2021-01-06T18:24:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/\"},\"wordCount\":304,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/\",\"name\":\"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=\",\"datePublished\":\"2021-01-06T18:24:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/","og_locale":"en_US","og_type":"article","og_title":"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO - Market Newsdesk","og_description":"NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Fortress Biotech, Inc. (NASDAQ: FBIO) from December 11, 2019 through October 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Fortress Biotech, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0info@pawarlawgroup.com\u00a0for information on the class action. According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: (1) IV Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the FDA would &hellip; Continue reading \"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T18:24:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO","datePublished":"2021-01-06T18:24:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/"},"wordCount":304,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/","name":"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. - FBIO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=","datePublished":"2021-01-06T18:24:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTY4MyMzOTA3NTE2IzIwODMxNDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-january-26-deadline-pawar-law-group-announces-a-securities-class-action-lawsuit-against-fortress-biotech-inc-fbio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IMPORTANT JANUARY 26 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Fortress Biotech, Inc. &#8211; FBIO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409760"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409760\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}